Top Markets
#1 Glidr Glidr +51.75%
#2 Akedo Akedo +50.81%
#3 DOVU DOVU +50.51%
#4 Cross Cross +49.17%
#5 Black Phoenix Black Phoenix +34.33%
#6 Velvet Velvet +32.01%
#7 OVERTAKE OVERTAKE +22.01%
#8 Cap Cap +17.55%
#9 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.87%
#10 Movement Movement +13.76%
Coin of the day
Glidr Glidr
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
ZyVersa Therapeutics, Inc. ZyVersa Therapeutics, Inc.

ZyVersa Therapeutics, Inc.

ZVSA
Rang in Aktien #38791
ZyVersa Therapeutics, Inc. is a biopharmaceutical firm in its clinical... ZyVersa Therapeutics, Inc. is a biopharmaceutical firm in its clinical development phase, dedicated to advancing and commercializing therapies for renal (kidney) and inflammatory disorders. The company's pipeline prominently features VAR 200, a cholesterol efflux modulator aimed at addressing kidney diseases such as focal segmental glomerulosclerosis, Alport syndrome, and diabetic kidney disease. Furthermore, ZyVersa is advancing IC 100, a pioneering inflammasome ASC inhibitor positioned to tackle a wide array of inflammatory conditions. The company maintains its corporate headquarters in Weston, Florida.
Aktienkurs
$0.099
Marktkapitalisierung
$801.50K
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
-34.44%
Land
US
Handel ZyVersa Therapeutics, Inc. (ZVSA)

Kategorie

Healthcare
Kursverlauf für ZyVersa Therapeutics, Inc. (ZVSA)
Höchster Schlusskurs: $0.11 am 2026-08-01

Niedrigster Schlusskurs: $3.45K am 2022-02-01
Kursverlauf der Aktie von ZyVersa Therapeutics, Inc. von 2022 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) 21.33%
2025 -87.48%
2024 -90.24%
2023 -99.49%
2022 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $506.92 29.88%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $843.33 29.26%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 7.13%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.25%
BE